NUTRA PHARMA CORP

Q: Jun 30 2026

Q: Jun 30 2026

Q: Mar 31 2026

FY: Dec 31 2025

Q: Sep 30 2025

Q: Jun 30 2025

Q: Mar 31 2025

FY: Dec 31 2024

Q: Sep 30 2024

Q: Jun 30 2024

Q: Mar 31 2024

FY: Dec 31 2023

Q: Sep 30 2023

Q: Jun 30 2023

Q: Mar 31 2023

FY: Dec 31 2022

Q: Sep 30 2022

Q: Sep 30 2022

Q: Jun 30 2022

Q: Jun 30 2022

Changes in Control of Registrant

Changes in Registrant's Certifying Accountant

5.02,7.01,8.01,9.01

4.01,9.01

4.01,9.01

7.01,8.01,9.01

5.02

3.02,5.01,5.03,9.01

4.01

5.02

3.03,5.03,9.01

5.07

8.01,9.01

4.01,9.01

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

1.01,3.02,9.01

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

5.02

1.01,3.02,9.01

5.02

Notice of Effectiveness

Amended Initial Registration Statement

Registration (IPO) statement under Securities Act of 1933

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

No description available

No description available

No description available

No description available

No description available

No description available

No description available

No description available

No description available

No description available

No description available

Definitive Proxy Statement

Preliminary Proxy Statement

No description available

Definitive Proxy Statement

Pure Raw Supplies, LLC

Pure Raw Supplies, LLC

DEITSCH RIK J

DEITSCH RIK J

none

none

DEITSCH RIK J

none

none

Coventry Enterprises,LLC

ORAN DAN

Lonky Stewart Alan

POTTRUCK GARRY

DEITSCH RIK J

Rumph Harold Henry

Lonky Stewart Alan

SARTORI BRUNO

SARTORI BRUNO

DEITSCH RIK J

Lonky Stewart Alan

Definitive information statement

Definitive information statement

No description available

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC